241 related articles for article (PubMed ID: 17715338)
21. AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
Kurai T; Hisayasu S; Kitagawa R; Migita M; Suzuki H; Hirai Y; Shimada T
Mol Ther; 2007 Jan; 15(1):38-43. PubMed ID: 17164773
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
23. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
24. Galactosylceramide sulfotransferase, arylsulfatase A and cerebroside sulfatase activity in different regions of developing rat brain.
van der Pal RH; Klein W; van Golde LM; Lopes-Cardozo M
Biochim Biophys Acta; 1990 Mar; 1043(1):91-6. PubMed ID: 1968763
[TBL] [Abstract][Full Text] [Related]
25. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder.
Saravanan K; Schaeren-Wiemers N; Klein D; Sandhoff R; Schwarz A; Yaghootfam A; Gieselmann V; Franken S
Neurobiol Dis; 2004 Jul; 16(2):396-406. PubMed ID: 15193296
[TBL] [Abstract][Full Text] [Related]
26. Telencephalic histopathology and changes in behavioural and neural plasticity in a murine model for metachromatic leukodystrophy.
Faldini E; Stroobants S; Lüllmann-Rauch R; Eckhardt M; Gieselmann V; Balschun D; D'Hooge R
Behav Brain Res; 2011 Sep; 222(2):309-14. PubMed ID: 21459117
[TBL] [Abstract][Full Text] [Related]
27. Myelination in the absence of UDP-galactose:ceramide galactosyl-transferase and fatty acid 2 -hydroxylase.
Meixner M; Jungnickel J; Grothe C; Gieselmann V; Eckhardt M
BMC Neurosci; 2011 Mar; 12():22. PubMed ID: 21366909
[TBL] [Abstract][Full Text] [Related]
28. Elevated sulfatide levels in neurons cause lethal audiogenic seizures in mice.
van Zyl R; Gieselmann V; Eckhardt M
J Neurochem; 2010 Jan; 112(1):282-95. PubMed ID: 19860853
[TBL] [Abstract][Full Text] [Related]
29. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
[TBL] [Abstract][Full Text] [Related]
30. Analysis of sulfatide and enzymes of sulfatide metabolism.
Jungalwala FB; Natowicz MR; Chaturvedi P; Newburg DS
Methods Enzymol; 2000; 311():94-105. PubMed ID: 10563314
[No Abstract] [Full Text] [Related]
31. The role and metabolism of sulfatide in the nervous system.
Eckhardt M
Mol Neurobiol; 2008; 37(2-3):93-103. PubMed ID: 18465098
[TBL] [Abstract][Full Text] [Related]
32. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy.
Hess B; Saftig P; Hartmann D; Coenen R; Lüllmann-Rauch R; Goebel HH; Evers M; von Figura K; D'Hooge R; Nagels G; De Deyn P; Peters C; Gieselmann V
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14821-6. PubMed ID: 8962139
[TBL] [Abstract][Full Text] [Related]
33. Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A.
Schuster T; Mühlstein A; Yaghootfam C; Maksimenko O; Shipulo E; Gelperina S; Kreuter J; Gieselmann V; Matzner U
J Control Release; 2017 May; 253():1-10. PubMed ID: 28215668
[TBL] [Abstract][Full Text] [Related]
34. Engineered arylsulfatase A with increased activity, stability and brain delivery for therapy of metachromatic leukodystrophy.
Yaghootfam C; Sylvester M; Turk B; Gieselmann V; Matzner U
Mol Ther; 2023 Oct; 31(10):2962-2974. PubMed ID: 37644722
[TBL] [Abstract][Full Text] [Related]
35. Metachromatic leukodystrophy: consequences of sulphatide accumulation.
Gieselmann V; Franken S; Klein D; Mansson JE; Sandhoff R; Lüllmann Rauch R; Hartmann D; Saravanan VP; De Deyn PP; D'Hooge R; Van Der Linden AM; Schaeren-Wiemers N
Acta Paediatr Suppl; 2003 Dec; 92(443):74-9; discussion 45. PubMed ID: 14989469
[TBL] [Abstract][Full Text] [Related]
36. Imaging of complex sulfatides SM3 and SB1a in mouse kidney using MALDI-TOF/TOF mass spectrometry.
Marsching C; Eckhardt M; Gröne HJ; Sandhoff R; Hopf C
Anal Bioanal Chem; 2011 Jul; 401(1):53-64. PubMed ID: 21359825
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.
Biffi A; Capotondo A; Fasano S; del Carro U; Marchesini S; Azuma H; Malaguti MC; Amadio S; Brambilla R; Grompe M; Bordignon C; Quattrini A; Naldini L
J Clin Invest; 2006 Nov; 116(11):3070-82. PubMed ID: 17080200
[TBL] [Abstract][Full Text] [Related]
38. Mannose 6-phosphate receptor-dependent endocytosis of lysosomal enzymes is increased in sulfatide-storing kidney cells.
Klein D; Yaghootfam A; Matzner U; Koch B; Braulke T; Gieselmann V
Biol Chem; 2009 Jan; 390(1):41-8. PubMed ID: 19007310
[TBL] [Abstract][Full Text] [Related]
39. Metachromatic leukodystrophy: recent research developments.
Gieselmann V
J Child Neurol; 2003 Sep; 18(9):591-4. PubMed ID: 14572136
[TBL] [Abstract][Full Text] [Related]
40. Reduced brain cholesterol content in arylsulfatase A-deficient mice.
Lütjohann D; Harzer K; Gieselmann V; Eckhardt M
Biochem Biophys Res Commun; 2006 Jun; 344(2):647-50. PubMed ID: 16630546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
